• D-Luciferin Sodium Salt in Firefly Luciferase Assays: Applie

  2026-05-26

  D-Luciferin sodium salt empowers sensitive, non-invasive bioluminescence imaging for monitoring cell viability, metabolism, and gene expression in both basic and translational oncology research. Discover how optimized workflows and troubleshooting strategies unlock the full potential of this firefly luciferase substrate in advanced immunotherapy applications.

• Applied Uses of Recombinant Mouse Macrophage Colony Stimulat

  2026-05-26

  Discover how APExBIO's Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag empowers precise macrophage culture, polarization, and disease modeling. This guide translates the latest epigenetic and metabolic findings into actionable protocols, troubleshooting, and translational research strategies.

• RITA (NSC 652287): Applied Workflows for Cancer Research

  2026-05-25

  RITA (NSC 652287) stands out as a potent MDM2-p53 inhibitor, enabling precise modulation of tumor suppressor pathways in both in vitro and in vivo cancer models. This article details best-practice workflows, protocol enhancements, and troubleshooting strategies for maximizing research impact with RITA in apoptosis and cytotoxicity assays.

• Repurposing Natural Compounds to Inhibit SARS-CoV-2: Docking

  2026-05-25

  This study explores the repurposing of natural vitamins as inhibitors of SARS-CoV-2 by targeting both the main protease (3CLpro) and the spike protein's receptor-binding domain. Using molecular docking and dynamics, the paper identifies several safe, affordable compounds with strong binding at critical viral sites, suggesting their potential for future antiviral therapeutics research.

• Strategic Use of ABT-263 (Navitoclax) in Translational Oncol

  2026-05-24

  Explore the mechanistic and translational rationale underlying the strategic deployment of ABT-263 (Navitoclax) in apoptosis research and oncology workflows. This article synthesizes evidence-backed guidance for researchers, benchmarks experimental parameters, and positions APExBIO’s ABT-263 as a gold-standard solution for modeling apoptotic mechanisms and overcoming resistance in cancer models.

• ETS1 Regulates Sumoylation-Dependent Mitophagy in BPD Models

  2026-05-23

  This study uncovers how the transcription factor ETS1 mitigates bronchopulmonary dysplasia (BPD) by targeting the SENP2/HSPA8/FUNDC1 axis and suppressing mitochondrial damage-induced autophagy. The findings highlight the critical role of SUMO1-mediated posttranslational modification in mitophagy regulation and suggest new avenues for molecular intervention in neonatal lung disease.

• Cimetidine: Mechanistic Leverage for Translational Oncology

  2026-05-22

  Explore how Cimetidine’s distinct H2 receptor modulation is reshaping translational research in gastrointestinal cancers and high-throughput barrier models. This article delivers mechanistic clarity, practical protocol parameters, and strategic insights for researchers seeking rigor and innovation in preclinical workflows.

• ATRX Loss Sensitizes Glioma Cells to RTK and PDGFR Inhibitor

  2026-05-22

  This study reveals that high-grade glioma cells lacking ATRX are especially vulnerable to receptor tyrosine kinase and platelet-derived growth factor receptor inhibitors. The findings highlight the importance of considering ATRX status in glioma drug screening and clinical trial design, opening new avenues for targeted therapy strategies.

• Improved In Vitro Metrics for Drug Response in Cancer Resear

  2026-05-21

  Schwartz's dissertation introduces a robust framework that distinguishes between relative viability and fractional viability in anti-cancer drug assays. This innovation enables clearer interpretation of drug-induced effects, advancing the precision of in vitro studies and supporting translational oncology research.

• Methyl-β-cyclodextrin: Technical Guide for Membrane Studies

  2026-05-21

  Methyl-β-cyclodextrin facilitates selective extraction of cholesterol and specific membrane lipids, supporting controlled investigation of membrane fluidity, lipid raft disruption, and cholesterol-dependent signaling pathways. It should be used exclusively in laboratory membrane research workflows and is not intended for diagnostic or medical purposes.

• Early Pheromone Sensing Drives Neurodegeneration in C. elega

  2026-05-20

  Peng et al. (2023) reveal that early developmental exposure to specific pheromones in C. elegans remodels neurodevelopment and accelerates age-related neurodegeneration. Their mechanistic insights link environmental chemical cues to neuronal health, highlighting pathways relevant to proteostasis and neurodegenerative disease modeling.

• ONX-0914 (PR-957): Precision Immunoproteasome Inhibition in

  2026-05-20

  This thought-leadership article explores how ONX-0914 (PR-957), a selective immunoproteasome inhibitor from APExBIO, empowers translational researchers to modulate immune responses with unprecedented specificity. We bridge mechanistic insights—grounded in proteasome subunit heterogeneity and cytokine blockade—to strategic guidance for modeling autoimmune and inflammatory diseases, referencing cutting-edge breast cancer studies and validated protocols. The article distinguishes itself by integrating recent evidence, actionable parameters, and a cross-domain perspective to guide next-generation therapeutic discovery.

• Midecamycin: Mechanistic Insights and Resistance Dynamics in

  2026-05-19

  Explore the advanced mechanistic profile of midecamycin, an acetoxy-substituted macrolide antibiotic, and its nuanced resistance dynamics in microbiology research. This article uniquely dissects molecular inhibition, resistance mechanisms, and cross-domain lessons from recent vascular injury models.

• 5-hme-dCTP: Unraveling 5hmC’s Contextual Roles in Plant Epig

  2026-05-19

  Explore the pivotal role of 5-hme-dCTP in decoding 5-hydroxymethylcytosine (5hmC) dynamics during plant drought response. This article leverages new single-base mapping insights for advanced epigenetic DNA modification research.

• PTGER4 Signaling Modulates HDAC Activity and SPINK4 in Recta

  2026-05-18

  Anbazhagan et al. uncover a regulatory axis in rectal epithelial cells, demonstrating that mesenchymal stromal cell-derived PGE2 activates PTGER4 signaling to modulate class IIa histone deacetylases and SPINK4 mRNA expression. This mechanistic insight provides new understanding of epithelial barrier regulation during inflammation and injury, with implications for mucosal healing in IBD.

16237 records 1/1083 page Next 12345 下5页 Last page